Home Biosimilar Antibodies Others Others Samrotamab (Anti-LRRC15 / LIB)
For research use only. Not for use in humans.

Samrotamab (Anti-LRRC15 / LIB)

Synonyms: null

Samrotamab (Anti-LRRC15 / LIB) is a fully human monoclonal antibody against LRRC15. MW: 145.5 kD.

Samrotamab (Anti-LRRC15 / LIB)

1 Citation

The Nobel Prize

17 Nobel Prize winners have used Selleck products

Shimon Sakaguchi

Nature Communications 2025,16, Article number:1325

David Baker

Dev Cell 2023, 58(20):2163-2180.e9.

David Julius

Cell 2017, 185-198.e16

Michael Houghton

Cell Chem Biol, 2020, 27(7):780-792.e5

Charles M. Rice

Cell 2018, 172(3):423-438.e25

Quality Control

Batch: Purity: 99% Protein concentration: 5.3mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Samrotamab (Anti-LRRC15 / LIB) is a fully human monoclonal antibody against LRRC15. MW: 145.5 kD.

Product Details

CAS No. 2052591-32-7
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05090865 RECRUITING Chronic Kidney Disease; Hyperkalemia University of Manitoba 2024-01-15
NCT05104073 COMPLETED Overweight and Obesity Milton S. Hershey Medical Center 2022-01-20
NCT05041959 COMPLETED Cigarette Smoking; Nicotine Dependence; Nicotine Withdrawal University of Oklahoma 2022-06-02
NCT06044610 COMPLETED Dehydration PepsiCo Global R&D 2023-05-08
NCT02189018 COMPLETED Peripheral Arterial Occlusive Disease Baltimore VA Medical Center 2014-08
NCT03809299 COMPLETED PreDiabetes Albert Einstein College of Medicine 2019-06-20

(data from https://clinicaltrials.gov, updated on 2026-01-16)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.